Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2

Elvan Ergülen, Bálint Bécsi, István Csomós, L. Fésüs, Kajal Kanchan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Transglutaminase 2 (TG2) is a ubiquitously expressed multifunctional member of the transglutaminase enzyme family. It has been implicated to have roles in many physiological and pathological processes such as differentiation, apoptosis, signal transduction, adhesion and migration, wound healing and inflammation. Previous studies revealed that TG2 has various intra-And extra-cellular interacting partners, which contribute to these processes. In the present study, we identified a molecular co-chaperone, DNAJA1, as a novel interacting partner of human TG2 using a GST pull-down assay and subsequent mass spectrometry analysis, and further confirmed this interaction via ELISA and surface plasmon resonance measurements. Interaction studies were also performed with domain variants of TG2 and results suggest that the catalytic core domain of TG2 is essential for the TG2-DNAJA1 interaction. Cross-linking activity was not essential for the interaction since DNAJA1 was also found to interact with the catalytically inactive form of TG2. Furthermore, we have showed that DNAJA1 interacts with the open form of TG2 and regulates its transamidation activity under both in vitro and in situ conditions. We also found that DNAJA1 is a glutamine donor substrate of TG2. Since DNAJA1 and TG2 are reported to regulate common pathological conditions such as neurodegenerative disorders and cancer, the findings in the present paper open up possibilities to explore molecular mechanisms behind TG2-regulated functions.

Original languageEnglish
Pages (from-to)3889-3901
Number of pages13
JournalBiochemical Journal
Volume473
Issue number21
DOIs
Publication statusPublished - 2016

Fingerprint

Substrates
Catalytic Domain
transglutaminase 2
Physiological Phenomena
Signal transduction
Molecular Chaperones
Transglutaminases
Surface Plasmon Resonance
Surface plasmon resonance
Pathologic Processes
Glutamine
Neurodegenerative Diseases
Wound Healing
Mass spectrometry
Assays
Signal Transduction
Mass Spectrometry
Adhesion
Enzyme-Linked Immunosorbent Assay
Apoptosis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2. / Ergülen, Elvan; Bécsi, Bálint; Csomós, István; Fésüs, L.; Kanchan, Kajal.

In: Biochemical Journal, Vol. 473, No. 21, 2016, p. 3889-3901.

Research output: Contribution to journalArticle

Ergülen, Elvan ; Bécsi, Bálint ; Csomós, István ; Fésüs, L. ; Kanchan, Kajal. / Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2. In: Biochemical Journal. 2016 ; Vol. 473, No. 21. pp. 3889-3901.
@article{9d06c95e75b246a688676fabd84373d3,
title = "Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2",
abstract = "Transglutaminase 2 (TG2) is a ubiquitously expressed multifunctional member of the transglutaminase enzyme family. It has been implicated to have roles in many physiological and pathological processes such as differentiation, apoptosis, signal transduction, adhesion and migration, wound healing and inflammation. Previous studies revealed that TG2 has various intra-And extra-cellular interacting partners, which contribute to these processes. In the present study, we identified a molecular co-chaperone, DNAJA1, as a novel interacting partner of human TG2 using a GST pull-down assay and subsequent mass spectrometry analysis, and further confirmed this interaction via ELISA and surface plasmon resonance measurements. Interaction studies were also performed with domain variants of TG2 and results suggest that the catalytic core domain of TG2 is essential for the TG2-DNAJA1 interaction. Cross-linking activity was not essential for the interaction since DNAJA1 was also found to interact with the catalytically inactive form of TG2. Furthermore, we have showed that DNAJA1 interacts with the open form of TG2 and regulates its transamidation activity under both in vitro and in situ conditions. We also found that DNAJA1 is a glutamine donor substrate of TG2. Since DNAJA1 and TG2 are reported to regulate common pathological conditions such as neurodegenerative disorders and cancer, the findings in the present paper open up possibilities to explore molecular mechanisms behind TG2-regulated functions.",
author = "Elvan Erg{\"u}len and B{\'a}lint B{\'e}csi and Istv{\'a}n Csom{\'o}s and L. F{\'e}s{\"u}s and Kajal Kanchan",
year = "2016",
doi = "10.1042/BCJ20160440",
language = "English",
volume = "473",
pages = "3889--3901",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "21",

}

TY - JOUR

T1 - Identification of DNAJA1 as a novel interacting partner and a substrate of human transglutaminase 2

AU - Ergülen, Elvan

AU - Bécsi, Bálint

AU - Csomós, István

AU - Fésüs, L.

AU - Kanchan, Kajal

PY - 2016

Y1 - 2016

N2 - Transglutaminase 2 (TG2) is a ubiquitously expressed multifunctional member of the transglutaminase enzyme family. It has been implicated to have roles in many physiological and pathological processes such as differentiation, apoptosis, signal transduction, adhesion and migration, wound healing and inflammation. Previous studies revealed that TG2 has various intra-And extra-cellular interacting partners, which contribute to these processes. In the present study, we identified a molecular co-chaperone, DNAJA1, as a novel interacting partner of human TG2 using a GST pull-down assay and subsequent mass spectrometry analysis, and further confirmed this interaction via ELISA and surface plasmon resonance measurements. Interaction studies were also performed with domain variants of TG2 and results suggest that the catalytic core domain of TG2 is essential for the TG2-DNAJA1 interaction. Cross-linking activity was not essential for the interaction since DNAJA1 was also found to interact with the catalytically inactive form of TG2. Furthermore, we have showed that DNAJA1 interacts with the open form of TG2 and regulates its transamidation activity under both in vitro and in situ conditions. We also found that DNAJA1 is a glutamine donor substrate of TG2. Since DNAJA1 and TG2 are reported to regulate common pathological conditions such as neurodegenerative disorders and cancer, the findings in the present paper open up possibilities to explore molecular mechanisms behind TG2-regulated functions.

AB - Transglutaminase 2 (TG2) is a ubiquitously expressed multifunctional member of the transglutaminase enzyme family. It has been implicated to have roles in many physiological and pathological processes such as differentiation, apoptosis, signal transduction, adhesion and migration, wound healing and inflammation. Previous studies revealed that TG2 has various intra-And extra-cellular interacting partners, which contribute to these processes. In the present study, we identified a molecular co-chaperone, DNAJA1, as a novel interacting partner of human TG2 using a GST pull-down assay and subsequent mass spectrometry analysis, and further confirmed this interaction via ELISA and surface plasmon resonance measurements. Interaction studies were also performed with domain variants of TG2 and results suggest that the catalytic core domain of TG2 is essential for the TG2-DNAJA1 interaction. Cross-linking activity was not essential for the interaction since DNAJA1 was also found to interact with the catalytically inactive form of TG2. Furthermore, we have showed that DNAJA1 interacts with the open form of TG2 and regulates its transamidation activity under both in vitro and in situ conditions. We also found that DNAJA1 is a glutamine donor substrate of TG2. Since DNAJA1 and TG2 are reported to regulate common pathological conditions such as neurodegenerative disorders and cancer, the findings in the present paper open up possibilities to explore molecular mechanisms behind TG2-regulated functions.

UR - http://www.scopus.com/inward/record.url?scp=85009353127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009353127&partnerID=8YFLogxK

U2 - 10.1042/BCJ20160440

DO - 10.1042/BCJ20160440

M3 - Article

C2 - 27551108

AN - SCOPUS:85009353127

VL - 473

SP - 3889

EP - 3901

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 21

ER -